SCYX · Scynexis Inc
United States · RS rating 63 · As of 2026-11-03
| Price | 3.94 USD |
|---|---|
| 1-day change | +3.4% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 20 / 27 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 30 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +118.8% |
| Sales growth Q/Q | +5482.6% |
| Distance from 52-week high | +30.5% |
| Market cap (USD) | $46.9M |